Gallery of new files
Jump to navigation
Jump to search
This special page shows the last uploaded files.
-
Ocrelizumab Adverse Reactions Table 2.png Yashasvi Aryaputra
02:44, 6 August 2018
1,110 × 1,122; 159 KB
-
Ocrelizumab Adverse Reactions Table 1.png Yashasvi Aryaputra
02:43, 6 August 2018
1,200 × 960; 152 KB
-
Ocrelizumab Clinical Studies Figure 2.png Yashasvi Aryaputra
19:09, 3 August 2018
1,210 × 1,238; 377 KB
-
Ocrelizumab Clinical Studies Table 2.png Yashasvi Aryaputra
19:08, 3 August 2018
1,212 × 1,090; 172 KB
-
Ocrelizumab Clinical Studies Figure 1.png Yashasvi Aryaputra
19:00, 3 August 2018
1,206 × 1,028; 316 KB
-
Ocrelizumab Clinical Studies Table 1.png Yashasvi Aryaputra
18:59, 3 August 2018
1,216 × 1,620; 292 KB
-
Ocrelizumab Patient Counseling Information 1.png Yashasvi Aryaputra
18:49, 3 August 2018
532 × 2,790; 1.4 MB
-
Ocrelizumab Patient Counseling Information.png Yashasvi Aryaputra
18:46, 3 August 2018
985 × 5,820; 2.33 MB
-
Secnidazole Pharmacokinetics Table 1.png Yashasvi Aryaputra
14:56, 3 August 2018
1,278 × 1,412; 243 KB
-
Secnidazole Clinical Studies Table 2.png Yashasvi Aryaputra
14:51, 3 August 2018
1,276 × 1,218; 218 KB
-
Secnidazole Clinical Studies Table 1.png Yashasvi Aryaputra
14:50, 3 August 2018
1,282 × 1,306; 254 KB
-
Secnidazole Patient Counseling Information.png Yashasvi Aryaputra
14:41, 3 August 2018
1,012 × 1,994; 1.41 MB
-
Sofosbuvir-velpatasvir-voxilaprevir Dosage Table.png Yashasvi Aryaputra
12:49, 3 August 2018
1,012 × 660; 144 KB
-
Sofosbuvir-velpatasvir-voxilaprevir Adverse Reactions Table.png Yashasvi Aryaputra
11:58, 3 August 2018
1,048 × 828; 122 KB
-
Sofosbuvir-velpatasvir-voxilaprevir Drug Interactions Table.png Yashasvi Aryaputra
03:55, 3 August 2018
466 × 2,586; 851 KB
-
Sofosbuvir-velpatasvir-voxilaprevir Pharmacokinetics Table 3.png Yashasvi Aryaputra
03:22, 3 August 2018
460 × 1,798; 598 KB
-
Sofosbuvir-velpatasvir-voxilaprevir Pharmacokinetics Table 2.png Yashasvi Aryaputra
03:17, 3 August 2018
796 × 710; 125 KB
-
Sofosbuvir-velpatasvir-voxilaprevir Pharmacokinetics Table 1.png Yashasvi Aryaputra
03:16, 3 August 2018
848 × 1,542; 219 KB
-
Sofosbuvir-velpatasvir-voxilaprevir Clinical Studies Table 2.png Yashasvi Aryaputra
03:11, 3 August 2018
820 × 2,448; 913 KB
-
Sofosbuvir-velpatasvir-voxilaprevir Clinical Studies Table 1.png Yashasvi Aryaputra
03:02, 3 August 2018
1,026 × 1,038; 218 KB
-
Sofosbuvir-velpatasvir-voxilaprevir Package Label.jpeg Yashasvi Aryaputra
02:58, 3 August 2018
744 × 352; 60 KB
-
Sofosbuvir-velpatasvir-voxilaprevir Patient Counseling Information.png Yashasvi Aryaputra
02:56, 3 August 2018
548 × 2,482; 1.36 MB
-
Tisagenlecleucel Adverse Reactions Table 7.png Yashasvi Aryaputra
14:21, 1 August 2018
1,256 × 908; 127 KB
-
Tisagenlecleucel Adverse Reactions Tables 5 and 6.png Yashasvi Aryaputra
14:20, 1 August 2018
550 × 2,452; 936 KB
-
Tisagenlecleucel Adverse Reactions Table 4.png Yashasvi Aryaputra
14:18, 1 August 2018
1,274 × 478; 81 KB
-
Tisagenlecleucel Adverse Reactions Table 3.png Yashasvi Aryaputra
14:17, 1 August 2018
1,274 × 628; 117 KB
-
Tisagenlecleucel Adverse Reactions Tables 1 and 2.png Yashasvi Aryaputra
14:12, 1 August 2018
552 × 2,744; 891 KB
-
Tisagenlecleucel Pharmacokinetics Table 1.png Yashasvi Aryaputra
13:06, 1 August 2018
1,274 × 1,376; 264 KB
-
Tisagenlecleucel Clinical Studies Table 3.png Yashasvi Aryaputra
13:02, 1 August 2018
1,274 × 1,290; 197 KB
-
Tisagenlecleucel Clinical Studies Table 2.png Yashasvi Aryaputra
12:59, 1 August 2018
1,266 × 442; 91 KB
-
Tisagenlecleucel Clinical Studies Table 1.png Yashasvi Aryaputra
12:56, 1 August 2018
498 × 1,550; 539 KB
-
Tisagenlecleucel Patient Counseling Information.png Yashasvi Aryaputra
19:00, 30 July 2018
562 × 2,624; 1.05 MB
-
Safinamide Clinical Studies Table 2.png Yashasvi Aryaputra
15:37, 30 July 2018
1,058 × 1,166; 189 KB
-
Safinamide Patient Counseling Information.png Yashasvi Aryaputra
15:06, 30 July 2018
436 × 2,700; 1.19 MB
-
Sarilumab Adverse Reactions Table 2.png Yashasvi Aryaputra
13:38, 30 July 2018
1,128 × 1,102; 187 KB
-
Sarilumab Adverse Reactions Table 1.png Yashasvi Aryaputra
13:36, 30 July 2018
1,136 × 1,364; 183 KB
-
Kevzara Patient Counseling Information.png Yashasvi Aryaputra
03:12, 30 July 2018
382 × 2,574; 1.12 MB
-
Coagulation factor IX, GlycoPEGylated (Rebinyn) Adverse Reactions Table.png Yashasvi Aryaputra
16:13, 27 July 2018
1,278 × 588; 82 KB
-
Coagulation factor IX, GlycoPEGylated (Rebinyn) Specific Populations Table.png Yashasvi Aryaputra
15:23, 27 July 2018
1,284 × 1,370; 166 KB
-
Coagulation factor IX, GlycoPEGylated (Rebinyn) Pharmacokinetics Table 4.png Yashasvi Aryaputra
13:42, 27 July 2018
1,280 × 932; 149 KB
-
Coagulation factor IX, GlycoPEGylated (Rebinyn) Pharmacokinetics Table 3.png Yashasvi Aryaputra
13:40, 27 July 2018
1,270 × 1,386; 221 KB
-
Coagulation factor IX, GlycoPEGylated (Rebinyn) Pharmacokinetics Table 2.png Yashasvi Aryaputra
13:39, 27 July 2018
1,282 × 1,130; 165 KB
-
Coagulation factor IX, GlycoPEGylated (Rebinyn) Pharmacokinetics Table 1.png Yashasvi Aryaputra
13:36, 27 July 2018
1,278 × 1,146; 174 KB
-
Coagulation factor IX, GlycoPEGylated (Rebinyn) Clinical Studies Table.png Yashasvi Aryaputra
03:54, 27 July 2018
1,178 × 926; 98 KB
-
Coagulation factor IX, GlycoPEGylated (Rebinyn) How Supplied Table.png Yashasvi Aryaputra
03:48, 27 July 2018
1,134 × 1,096; 170 KB
-
Coagulation factor IX, GlycoPEGylated (Rebinyn) Package Label 7.jpeg Yashasvi Aryaputra
19:48, 25 July 2018
346 × 285; 21 KB
-
Coagulation factor IX, GlycoPEGylated (Rebinyn) Package Label 6.jpeg Yashasvi Aryaputra
19:46, 25 July 2018
624 × 235; 26 KB
-
Coagulation factor IX, GlycoPEGylated (Rebinyn) Package Label 5.jpeg Yashasvi Aryaputra
19:45, 25 July 2018
624 × 230; 25 KB
-
Coagulation factor IX, GlycoPEGylated (Rebinyn) Package Label 4.jpeg Yashasvi Aryaputra
19:43, 25 July 2018
624 × 251; 26 KB
-
Coagulation factor IX, GlycoPEGylated (Rebinyn) Package Label 3.jpeg Yashasvi Aryaputra
19:41, 25 July 2018
624 × 645; 49 KB
-
Coagulation factor IX, GlycoPEGylated (Rebinyn) Package Label 2.jpeg Yashasvi Aryaputra
19:36, 25 July 2018
624 × 637; 47 KB
-
Coagulation factor IX, GlycoPEGylated (Rebinyn) Package Label 1.jpeg Yashasvi Aryaputra
19:35, 25 July 2018
624 × 638; 48 KB
-
Rabies immune globulin (KedRab) Adverse Reactions Table.png Yashasvi Aryaputra
17:42, 25 July 2018
1,302 × 1,352; 203 KB
-
Rabies immune globulin (KedRab) Pharmacokinetics Table 2.png Yashasvi Aryaputra
16:54, 25 July 2018
1,252 × 632; 147 KB
-
Rabies immune globulin (KedRab) Pharmacokinetics Figure 1.png Yashasvi Aryaputra
16:52, 25 July 2018
1,282 × 812; 280 KB
-
Rabies immune globulin (KedRab) Pharmacokinetics Table 1.png Yashasvi Aryaputra
16:49, 25 July 2018
1,274 × 706; 143 KB
-
Rabies immune globulin (KedRab) Clinical Studies Table.png Yashasvi Aryaputra
16:42, 25 July 2018
1,300 × 958; 184 KB
-
Rabies immune globulin (KedRab) Package Label 4.jpeg Yashasvi Aryaputra
16:26, 25 July 2018
980 × 370; 95 KB
-
Rabies immune globulin (KedRab) Package Label 3.jpeg Yashasvi Aryaputra
16:25, 25 July 2018
991 × 931; 160 KB
-
Rabies immune globulin (KedRab) Package Label 2.jpeg Yashasvi Aryaputra
16:25, 25 July 2018
995 × 486; 127 KB
-
Rabies immune globulin (KedRab) Package Label 1.jpeg Yashasvi Aryaputra
16:24, 25 July 2018
977 × 772; 170 KB
-
Ribociclib Adverse Reactions Table 6.png Yashasvi Aryaputra
14:56, 25 July 2018
1,078 × 1,716; 542 KB
-
Ribociclib Adverse Reactions Table 5.png Yashasvi Aryaputra
14:54, 25 July 2018
1,102 × 2,486; 896 KB
-
Ribociclib Adverse Reactions Table 4.png Yashasvi Aryaputra
14:52, 25 July 2018
1,098 × 1,766; 560 KB
-
Ribociclib Adverse Reactions Table 3.png Yashasvi Aryaputra
14:51, 25 July 2018
1,100 × 2,146; 812 KB
-
Ribociclib Adverse Reactions Tables 1 and 2.png Yashasvi Aryaputra
14:48, 25 July 2018
732 × 2,778; 711 KB
-
Ribociclib Clinical Studies Table 3 and Figure 3.png Yashasvi Aryaputra
13:25, 25 July 2018
1,290 × 1,564; 375 KB
-
Ribociclib Clinical Studies Table 2 and Figure 2.png Yashasvi Aryaputra
13:24, 25 July 2018
1,296 × 1,554; 333 KB
-
Ribociclib Clinical Studies Table 1 and Figure 1.png Yashasvi Aryaputra
13:22, 25 July 2018
1,316 × 1,532; 300 KB
-
Ribociclib Patient Counseling Information.png Yashasvi Aryaputra
12:57, 25 July 2018
472 × 2,742; 1.13 MB
-
Plecanatide Adverse Reactions Table 2.png Yashasvi Aryaputra
03:03, 25 July 2018
1,288 × 618; 122 KB
-
192px-Crescentic glomerulonephritis (1).jpg Jogeet singh sekhon
18:49, 24 July 2018
192 × 145; 18 KB
-
Plecanatide Clinical Studies Table 2.png Yashasvi Aryaputra
18:38, 20 July 2018
1,252 × 1,648; 280 KB
-
Plecanatide Clinical Studies Table 1.png Yashasvi Aryaputra
18:34, 20 July 2018
1,108 × 1,110; 170 KB
-
Plecanatide Patient Counseling Information.png Yashasvi Aryaputra
17:57, 20 July 2018
588 × 2,716; 1.41 MB
-
Lesinurad-Allopurinol Adverse Reactions Table 4.png Yashasvi Aryaputra
15:24, 20 July 2018
1,188 × 504; 85 KB
-
Lesinurad-Allopurinol Adverse Reactions Tables 2 and 3.png Yashasvi Aryaputra
15:22, 20 July 2018
1,182 × 1,644; 311 KB
-
Lesinurad-Allopurinol Adverse Reactions Table 1.png Yashasvi Aryaputra
15:21, 20 July 2018
1,194 × 776; 156 KB
-
Lesinurad-Allopurinol Pharmacokinetics Figure 2.png Yashasvi Aryaputra
14:33, 20 July 2018
1,272 × 980; 370 KB
-
Lesinurad-Allopurinol Pharmacokinetics Figure 1.png Yashasvi Aryaputra
14:32, 20 July 2018
1,276 × 964; 389 KB
-
Lesinurad-Allopurinol Clinical Studies Table .png Yashasvi Aryaputra
14:15, 20 July 2018
1,206 × 622; 137 KB
-
Lesinurad-Allopurinol Clinical Studies Figure .png Yashasvi Aryaputra
14:13, 20 July 2018
1,294 × 864; 158 KB
-
Lesinurad-Allopurinol How Supplied Table.png Yashasvi Aryaputra
14:09, 20 July 2018
1,212 × 826; 158 KB
-
Lesinurad-Allopurinol Package Label 2.jpeg Yashasvi Aryaputra
14:06, 20 July 2018
1,419 × 785; 190 KB
-
Lesinurad-Allopurinol Package Label 1.jpeg Yashasvi Aryaputra
14:06, 20 July 2018
1,422 × 783; 186 KB
-
Lesinurad-Allopurinol Patient Counseling Information.png Yashasvi Aryaputra
14:02, 20 July 2018
452 × 2,580; 1.07 MB
-
Naldemedine Adverse Reactions Tables 1 and 2.png Yashasvi Aryaputra
13:22, 20 July 2018
1,266 × 1,626; 258 KB
-
Naldemedine Drug Interactions Table.png Yashasvi Aryaputra
13:19, 20 July 2018
1,284 × 1,422; 287 KB
-
Naldemedine Structural Formula WIKI.png Yashasvi Aryaputra
13:05, 20 July 2018
1,016 × 1,128; 215 KB
-
Naldemedine Patient Counseling Information.png Yashasvi Aryaputra
11:51, 20 July 2018
798 × 2,482; 1.6 MB
-
Ledipasvir-Sofosbuvir Pediatric Dosage Table.png Yashasvi Aryaputra
18:21, 18 July 2018
1,200 × 830; 184 KB
-
Ledipasvir-Sofosbuvir Adult Dosage Table.png Yashasvi Aryaputra
18:17, 18 July 2018
868 × 1,492; 774 KB
-
Ledipasvir-Sofosbuvir Pharmacokinetics Table 3.png Yashasvi Aryaputra
17:47, 18 July 2018
1,080 × 1,494; 907 KB
-
Ledipasvir-Sofosbuvir Adverse Reactions Table 2.png Yashasvi Aryaputra
17:21, 18 July 2018
1,156 × 890; 137 KB
-
Ledipasvir-Sofosbuvir Adverse Reactions Table 1.png Yashasvi Aryaputra
17:20, 18 July 2018
1,038 × 662; 90 KB
-
Ledipasvir-Sofosbuvir Drug Interactions Table.png Yashasvi Aryaputra
17:13, 18 July 2018
592 × 2,830; 1.2 MB
-
Ledipasvir-Sofosbuvir Pharmacokinetics Table 2.png Yashasvi Aryaputra
16:11, 18 July 2018
692 × 2,378; 918 KB
-
Ledipasvir-Sofosbuvir Pharmacokinetics Table 1.png Yashasvi Aryaputra
15:47, 18 July 2018
1,162 × 446; 91 KB
-
Ledipasvir-Sofosbuvir Clinical Studies Table 10.png Yashasvi Aryaputra
15:33, 18 July 2018
1,074 × 1,242; 248 KB
-
Ledipasvir-Sofosbuvir Clinical Studies Table 9.png Yashasvi Aryaputra
15:29, 18 July 2018
1,082 × 746; 133 KB
-
Ledipasvir-Sofosbuvir Clinical Studies Table 8.png Yashasvi Aryaputra
15:22, 18 July 2018
1,056 × 1,246; 209 KB
-
Ledipasvir-Sofosbuvir Clinical Studies Table 7.png Yashasvi Aryaputra
15:20, 18 July 2018
1,072 × 1,186; 197 KB
-
Ledipasvir-Sofosbuvir Clinical Studies Table 6.png Yashasvi Aryaputra
15:17, 18 July 2018
1,082 × 864; 158 KB
-
Ledipasvir-Sofosbuvir Clinical Studies Table 5.png Yashasvi Aryaputra
15:15, 18 July 2018
1,108 × 870; 146 KB
-
Ledipasvir-Sofosbuvir Clinical Studies Table 4.png Yashasvi Aryaputra
15:14, 18 July 2018
1,094 × 822; 152 KB
-
Ledipasvir-Sofosbuvir Clinical Studies Table 2.png Yashasvi Aryaputra
15:13, 18 July 2018
1,094 × 1,194; 215 KB
-
Ledipasvir-Sofosbuvir Clinical Studies Table 3.png Yashasvi Aryaputra
15:12, 18 July 2018
1,082 × 630; 125 KB
-
Ledipasvir-Sofosbuvir Clinical Studies Table 1.png Yashasvi Aryaputra
15:11, 18 July 2018
866 × 1,354; 697 KB
-
Ledipasvir-Sofosbuvir Patient Counseling Information.png Yashasvi Aryaputra
14:58, 18 July 2018
616 × 2,792; 1.35 MB
-
Inotuzumab Ozogamicin Dosage Tables 2-3-4.png Yashasvi Aryaputra
14:21, 18 July 2018
600 × 2,590; 1.13 MB
-
Inotuzumab Ozogamicin Adverse Reactions Table 2.png Yashasvi Aryaputra
14:04, 18 July 2018
762 × 1,912; 559 KB
-
Inotuzumab Ozogamicin Adverse Reactions Table 1.png Yashasvi Aryaputra
14:02, 18 July 2018
534 × 2,652; 911 KB
-
Inotuzumab Ozogamicin Administration Table.png Yashasvi Aryaputra
13:36, 18 July 2018
1,044 × 1,138; 252 KB
-
Inotuzumab Ozogamicin Structural Formula.png Yashasvi Aryaputra
13:28, 18 July 2018
1,288 × 648; 273 KB
-
Inotuzumab Ozogamicin Clinical Studies Figure.png Yashasvi Aryaputra
13:19, 18 July 2018
1,308 × 736; 336 KB
-
Inotuzumab Ozogamicin Clinical Studies Table.png Yashasvi Aryaputra
13:17, 18 July 2018
834 × 1,728; 937 KB
-
Etelcalcetide Adverse Reactions Table.png Yashasvi Aryaputra
01:35, 18 July 2018
1,300 × 1,098; 194 KB